SilicoLife, the Portuguese firm designing optimised microorganisms and novel pathways for biotech applications, has just concluded two Series A fundraising rounds to the total tune of €9.8 million to be invested in 'unmet needs' within the dietary...
DuPont Nutrition and Health further strengthen their probiotic credentials collaborating with the APC Microbiome Institute in the first of a series of partnerships intended to push microbiome science to the forefront.
Food based start-ups in Europe will soon have access to venture capital funds, simplified tax filings and liberalised insolvency laws as part of the EU commission’s new ‘Start-up Scale–up’ initiative
New Crop Capital is a venture capital fund that only invests in sustainable start-ups developing cultured and plant-based meat, dairy and egg products. But it's not just about saving the planet: “There are billions to be made annually in this space,”...
A hangover from the negative publicity of the past year has stalled M&A and financing activity in dietary supplements, even as this activity booms in other categories of the health and wellness space, according to investment group Nutrition Capital...
Tate & Lyle will pump up to £30m ($48m/€36.5m) over eight-years in a new venture capital fund that will invest in start-ups and expansion-stage companies in food sciences and enabling technologies.
The US operation of financially stricken resveratrol supplier, Fluxome, says the cash crisis that has forced closure of its Danish research facility, will not halt resveratrol supply through its US operation.
Global resveratrol player Fluxome has 8-12 weeks to raise millions of euros to fund a research switch to omega-3, or face bankruptcy, its chairman told NutraIngredients this morning.
Vitafoods Europe is launching a unique programme of research presentations and poster sessions to showcase the latest scientific developments in the industry at this year’s show.
Vitafoods Europe 2012 will see posters sessions for the first time, with the organisers claiming such a development allows scientists to demonstrate their original research for a potential new product or process that is commercially feasible.
New Zealand Wool Equities is has reached an unconditional agreement
to sell its research, development and IP operation Canesis to
state-owned Agresearch, leaving the holding company with
nutraceutical company Keratec as its only major...
BioPacificVentures has made an offer to acquire an eight per cent
share in Wool Equities, owner of New Zealand biotech Keratec - and
sources say it may seek a full take-over position.
Food and beverage makers could soon tap into a range of new
ingredients with a healthy twist as sugar and sweetener firm Tate
& Lyle launches a new venture capital arm to focus on
next-generation ingredients.
Fresh air, agricultural expertise, research resources… and NZ$100m
(€48m) funding: BioPacificVentures is proposing an attractive
package to European and American functional food start-ups that are
prepared to relocate all or part...
Chemicals giant BASF has invested €2 million in a small German
encapsulation business that claims to have developed a novel
process that allows for efficient ingredient delivery.
Up-and-coming Advanced Bionutrition (ABN) has captured the
attention of venture capitalists in the biotechnology field,
raising $7.5 million in a second round of private equity funding.
Vanson HaloSource, the US company which specialises in
chitosan-based products, has completed a new round of financing
which will help it finance the development of new supplement
products.
Herbalife, the weight management and nutritional supplement
company, is to be bought by two private equity firms, Whitney &
Co and Golden Gate Capital, for around $685 million (€773.6m). The
current Herbalife management will continue...
